ACTRN12617000847314已完成未知
The Effects of High Intensity Exercise on Cardiovascular Function in Men with Metastatic Castrate-Resistant Prostate Cancer (MCRPC): a sub study of GAP4-QLD INTense Exercise foR surVivAL among men with MCRPC (INTERVAL - MCRPC)
niversity of Queensland0 个研究点目标入组 5 人开始时间: 2017年6月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
il as of yet.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •As participants for the sub-study will be recruited through the GAP4 INTERVAL clinical trial (Trial ID: NCT02730338), the key inclusion criteria have been listed previously in INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL) (Trial ID: NCT02730338).
- •No additional key inclusion criteria are required to be met for involvement in this sub-study.
排除标准
- •As participants for the sub-study will be recruited through the GAP4 INTERVAL clinical trial (Trial ID: NCT02730338), the key exclusion criteria have been listed previously in INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL) (Trial ID: NCT02730338).
- •No additional key exclusion criteria are required to be met for involvement in this sub-study.
研究者
相似试验
尚未招募
Unknown
High Intensity Exercise & its Effect in middle age vs old age adults with Low Back PaiCTRI/2023/05/053255niversity Grants Commission
尚未招募
不适用
Effect of High Intensity Interval exercise on ability of heart and lungs, balance and walking ability in hearing loss childreCTRI/2022/11/047167Bhagya Lakshmi K
已完成
3 期
Effect of exercise intensity on cardiac and vascular function, and intra-abdominal fat in obese children and adolescents.Obesity and overweight in children and adolescentsDiet and Nutrition - ObesityACTRN12613001037796Professor Jeff Coombes30
已完成
不适用
Cardiovascular Effects of High-Intensity Interval Training (HIIT)Healthy Sedentary Adults With BP <140/90NCT03602170University of Delaware20
Unknown
不适用
The Syndrome X-ercise Study SYNDEXAnginaNCT02905630Helse Stavanger HF30